Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement.
Document Type
Journal Article
Publication Date
3-1-2018
Journal
Prim Care Companion CNS Disord
Volume
20
Issue
2
DOI
10.4088/PCC.17nr02235
Keywords
Animals; Cognitive Dysfunction; Drug Therapy, Combination; Electroconvulsive Therapy; Galantamine; Humans; Kynurenic Acid; Memantine; Mental Disorders; Nervous System Diseases; Nootropic Agents
APA Citation
Koola, M. (2018). Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement.. Prim Care Companion CNS Disord, 20 (2). http://dx.doi.org/10.4088/PCC.17nr02235
Peer Reviewed
1
